COVID boosters can’t outpace new mutations. Here’s why they still work
Paul Offit of the Perelman School of Medicine explains why it doesn’t matter which variant to target when it comes to vaccine-booster development.
・ From Wired
Paul Offit of the Perelman School of Medicine explains why it doesn’t matter which variant to target when it comes to vaccine-booster development.
・ From Wired